发明公开
- 专利标题： USE OF FRUCTOSE-BASED COMPOUNDS FOR THE DIAGNOSIS OF CANCER
- 专利标题（中）： 果糖使用基于化合物检测癌症
-
申请号： EP06824858.2申请日： 2006-08-24
-
公开(公告)号： EP1917042A2公开(公告)日： 2008-05-07
- 发明人: HEANEY, Anthony, P. , HUI, Hongxiang , WAXMAN, Alan
- 申请人： Cedars-Sinai Medical Center
- 申请人地址： 8700 Beverley Boulevard Los Angeles, CA 90048 US
- 专利权人： Cedars-Sinai Medical Center
- 当前专利权人： Cedars-Sinai Medical Center
- 当前专利权人地址： 8700 Beverley Boulevard Los Angeles, CA 90048 US
- 代理机构： Hutter, Anton
- 优先权： US710762P 20050824; US715514P 20050909
- 国际公布： WO2007025282 20070301
- 主分类号： A61K49/00
- IPC分类号： A61K49/00
摘要：
This invention relates to compositions, methods utilizing fructose and other monosaccharides for the diagnosis of cancer. Cancer cells have shown a higher level of fructose utilization as compared to glucose. Further, cancer cells have shown a preferential use of fructose for nucleic acid synthesis. The present invention takes advantage of these features and provides for fructose or fructose-based compositions for the diagnosis of cancer using imaging techniques such as positron emission tomography.
公开/授权文献
- EP1917042B1 USE OF FRUCTOSE-BASED COMPOUNDS FOR THE DIAGNOSIS OF CANCER 公开/授权日：2014-10-08
信息查询
